Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Sarepta Therapeutics Inc (NASDAQ:SRPT)

40.93
Delayed Data
As of 4:00pm ET
 +6.85 / +20.10%
Today’s Change
20.30
Today|||52-Week Range
63.73
+49.22%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Year
Trend

2013

2014

2015

2016
Revenue and IncomeNet Revenues14.2M9.8M1.3M5.4M
 
 
 
 
 
Cost of Goods Sold------130.0K
 
 
Depreciation And Amortization1.3M3.7M5.2M5.6M
 
 
 
 
 
 
Operating ExpensesGross Income-------320.0K
 
 
General Expenses101.9M139.7M207.0M261.8M
 
 
 
 
 
Research And Development71.7M94.1M146.4M186.3M
 
 
 
 
 
Total Operating Expenses103.2M143.4M212.3M267.6M
 
 
 
 
 
 
Non-Operating ExpensesOperating Income-89.0M-133.7M-211.0M-262.2M
 
 
 
 
 
Extraordinary Charge-23.3M-2.8M-9.2M-4.6M
 
 
 
 
 
Interest Expense On Debt------535.0K
 
 
Other Expenses200.0K679.0K0.000.00
 
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income-112.0M-135.8M-220.0M-267.3M
 
 
 
 
 
Net Income-112.0M-135.8M-220.0M-267.3M
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS33.9M40.0M42.3M48.7M
 
 
 
 
 
Shares To Calculate EPS Diluted33.9M40.0M42.3M48.7M
 
 
 
 
 
 
Earnings Per ShareEPS-$3.31-$3.39-$5.20-$5.49
 
 
 
 
 
EPS Diluted-$3.31-$3.39-$5.20-$5.49